["Severity": "Moderate Or Severe"]

Performance/Reporting Period

2022

Value Set Description from VSAC

Clinical Focus: The purpose of this value set is to represent concepts of severe and moderate levels of severity.
Data Element Scope: This value set may use a model element related to Severity.
Inclusion Criteria: Includes concepts that represent a Allergy/Intolerance, Adverse Event, Diagnosis, or Symptom with a severity of severe and moderate levels.
Exclusion Criteria: No exclusions.

Constrained to codes in the Severity: Moderate Or Severe value set (2.16.840.1.113883.3.526.3.1092)

QDM Attribute and Definition (QDM Version 5.5 Guidance Update)

severity

Indicates the intensity of the specified datatype (e.g., persistent, moderate, or severe).

eCQMs using this data element:

CMS135v10 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)